Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07020286

Prince of Wales Hospital Structural Heart Registry

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Prince of Wales Hospital, Shatin, Hong Kong · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers

Summary

Structural heart disease refers to a group of cardiac defects other than coronary artery disease. Structural heart intervention is a rapidly growing field in cardiology. In the past decade, there has been paradigm shift in the management of structural heart disease from conventional open-heart surgery to transcatheter interventions. With increasing evidence supporting structural heart interventions including transcatheter aortic valve implantation or transcatheter edge to edge repair, there has important updates in recent guidelines in treating structural heart disease. Besides, new device innovations bloomed over the past few years and had expanded the possible treatment options for high surgical risk patients. Some breakthrough devices had been approved recently by the US Food and Drug Administration and some other devices are occasionally used on compassionate ground. However, there has been lack of data in structural heart interventions in Asia Pacific regions outside Japan \[8\]. In this study, we would like to analyze the epidemiological trends, patient characteristics, procedural outcomes and clinical outcomes of structural heart interventions, and compare them with historical cohorts, matched cohort receiving medical therapy and matched cohort receiving open heart surgeries.

Conditions

Interventions

TypeNameDescription
PROCEDUREStructural heart interventionsThe study allows us to understand the trend of transcatheter interventions in structural heart disease, clinical outcomes and allows the comparison of the outcomes of structural heart interventions to medical therapy and surgery at PWH, and to HA hospitals.

Timeline

Start date
2024-08-01
Primary completion
2029-09-30
Completion
2030-03-31
First posted
2025-06-13
Last updated
2025-06-13

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT07020286. Inclusion in this directory is not an endorsement.